Scott Steiger, MD

HS Clinical Professor

General Internal Medicine, General Internal Medicine ZSFG

Since growing up in southeastern Kansas, Dr. Steiger has moved all over the country for school and jobs, landing on faculty at UCSF in 2012 at the Mt. Zion campus and transitioning to the San Francisco General campus in 2016. Board-certified in both internal medicine and addiction medicine, Dr. Steiger is the Deputy Medical Director of the Opiate Treatment Outpatient Program at SF General, where he also maintains a primary care practice and attends on the inpatient Addiction Care Team. His primary academic interest is in teaching about addiction and its treatments.

Education
Residency, 2008 - Internal Medicine, University of Washington
M.D., 2005 - , Washington University
B.S., 1998 - Biology and History, Duke University
Honors and Awards
  • Excellence in Interprofessional Teaching Award, UCSF Academy of Medical Educators, 2020
  • Best Workshop, Association for Medical Education and Research on Substance Abuse, 2016
  • Fellow, American College of Physicians, 2015
  • Fellow, American Society of Addiction Medicine, 2015
  • Excellence in Teaching Award, UCSF Academy of Medical Educators, 2015
Publications

  1. Suen LW, Steiger S, Shapiro B, Castellanos S, Joshi N, Lambdin BH, Knight KR. "Get in and get out, get on with life": Patient and provider perspectives on methadone van implementation for opioid use disorder treatment. The International journal on drug policy 2023. PMID: 37778132


  2. Tierney HR, Takimoto SW, Azari S, Steiger S, Martin M. Predictors of Linkage to an Opioid Treatment Program and Methadone Treatment Retention following Hospital Discharge in a Safety-Net Setting. Substance use & misuse 2023. PMID: 37194561


  3. Buresh M, Nahvi S, Steiger S, Weinstein ZM. Adapting methadone inductions to the fentanyl era. Journal of substance abuse treatment 2022. PMID: 35870437


  4. Checkley L, Steiger S, Knight KR. "I wanted something that was more flexible": A qualitative study of patient preferences on choosing buprenorphine over methadone in a large, safety-net hospital opioid treatment program. TO REMOVE 2022. PMID: 35112998


  5. Martin M, Snyder HR, Coffa D, Steiger S, Clement JP, Ranji SR, Azari S, Nguyen OK, Lum PJ. Time to ACT: launching an Addiction Care Team (ACT) in an urban safety-net health system. BMJ open quality 2021. PMID: 33500326


  6. Incze MA, Steiger S. What Should I Know About Opioids? JAMA internal medicine 2019. PMID: 30882852


  7. Freise JE, McCarthy EE, Guy M, Steiger S, Sheu L. Increasing Naloxone Co-prescription for Patients on Chronic Opioids: a Student-Led Initiative. Volume 33 of Issue 6. Journal of general internal medicine 2018. PMID: 29556799


  8. Bauer SR, Hitchner L, Harrison H, Gerstenberger J, Steiger S. Predictors of higher-risk chronic opioid prescriptions in an academic primary care setting. Volume 37 of Issue 1. Substance abuse 2016. PMID: 26848633


  9. Wamsley MA, Steiger S, Julian KA, Gleason N, O'Sullivan PS, Guy M, Satterfield JM. Teaching residents screening, brief intervention, and referral to treatment (SBIRT) skills for alcohol use: Using chart-stimulated recall to assess curricular impact. Volume 37 of Issue 3. Substance abuse 2015. PMID: 26675123


  10. Satre DD, Manuel JK, Larios S, Steiger S, Satterfield J. Cultural Adaptation of Screening, Brief Intervention and Referral to Treatment Using Motivational Interviewing. Volume 9 of Issue 5. Journal of addiction medicine 2015. PMID: 26428360